Metrics to compare | VIROG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVIROGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.6x | 24.6x | −0.5x | |
PEG Ratio | −0.26 | −0.47 | 0.00 | |
Price/Book | 5.9x | 1.9x | 2.6x | |
Price / LTM Sales | 10.9x | 1.8x | 3.0x | |
Upside (Analyst Target) | - | 13.5% | 58.6% | |
Fair Value Upside | Unlock | 28.5% | 10.2% | Unlock |
ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidimetric immunoassay for quantitative measurement of suPAR in human plasma; suPARnostic AUTO Flex ELISA kit, a fully quantitative immunoassay designed for accurate and reliable measurement of soluble urokinase plasminogen activator receptor in human plasma; and suPARnostic Quick Triage, a test for rapid, quantitative measurement of suPAR levels. ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.